NCT04668417

Brief Summary

This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder letter for the second dose of influenza vaccine (reminder messages sent via the patient portal) with a direct appointment scheduling link included in the reminder and 2) a reminder letter for the second dose of influenza vaccine, but no direct appointment scheduling link included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
698

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

December 15, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

May 28, 2021

Status Verified

May 1, 2021

Enrollment Period

4 months

First QC Date

December 9, 2020

Last Update Submit

May 26, 2021

Conditions

Keywords

VaccinationReminder RecallPatient Portal

Outcome Measures

Primary Outcomes (1)

  • Number of patients who received a second dose of influenza vaccine

    Receipt of a second dose of influenza vaccine (between 12/15/2020 and 4/1/21) among patients. Outcomes will be assessed via vaccine data extraction from the electronic health record and external claims and pharmacy data. The patient must also be an active UCLA Health MyChart user (\>= 1 login over the last 12 months from 12/15/2020), excluding activity on the user's initial profile activation date. Individuals not affiliated with any primary care practice will be excluded from the analysis.

    3.5 months

Study Arms (2)

Reminders with direct scheduling link

ACTIVE COMPARATOR

Patient proxy receives a reminder/recall messages regarding second dose influenza vaccination via the patient portal with a link enabling direct scheduling

Behavioral: Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link

Reminders with no direct scheduling link

ACTIVE COMPARATOR

Patient proxy receives a reminder/recall messages regarding second dose influenza vaccination via the patient portal with no direct scheduling link

Behavioral: Portal Reminders for Second Dose of Influenza Vaccine without Direct Scheduling Link

Interventions

Patient proxy receives reminder/recall messages via the patient portal to get a second dose of influenza vaccine with a direct scheduling link included, enabling the patient to directly schedule a flu vaccination only visit

Reminders with direct scheduling link

Patient proxy receives reminder/recall messages via the patient portal to get a second dose of influenza vaccine with no direct scheduling link included

Reminders with no direct scheduling link

Eligibility Criteria

Age6 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patient within the UCLA Health System identified as a primary care patient per an internal algorithm
  • Identified as being overdue for a second dose of influenza vaccine.

You may not qualify if:

  • Patient within the UCLA Health System not identified as a primary care patient per an internal algorithm
  • Not due for a second dose of influenza vaccine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California LA

Los Angeles, California, 99095, United States

Location

MeSH Terms

Conditions

Influenza, HumanRespiratory Tract Infections

Condition Hierarchy (Ancestors)

InfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Study Officials

  • Peter G Szilagyi, MD, MPH

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

December 9, 2020

First Posted

December 16, 2020

Study Start

December 15, 2020

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

May 28, 2021

Record last verified: 2021-05

Locations